Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's disease

Journal of Bone and Mineral Research

Volumn 19, Issue 7, 2004, Pages 1154-1164

  Kurihara, Noriyoshi ^a   Reddy, Sakamuri V ^a   Araki, Norie ^b   Ishizuka, Seiichi ^c   Ozono, Keiichi ^d   Cornish, Jillian ^e   Cundy, Tim ^e   Singer, Frederick R ^f   Roodman, G David ^a,g,h  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c TEIJIN LTD   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

^f John Wayne Cancer Center   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

1,25 dihydroxyvitamin D3; Bone marrow cultures; Osteoclast formation; Paget's disease; TAFII 17

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BINDING PROTEIN; CALCITRIOL; CHIMERIC PROTEIN; NUCLEOCAPSID PROTEIN; TATA BINDING PROTEIN ASSOCIATED FACTOR; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; COMPLEMENTARY DNA; CORE PROTEIN; DIHYDROXY VITAMIN D3; DIHYDROXY-VITAMIN D3; DRUG DERIVATIVE; NP PROTEIN; NUCLEOPROTEIN; TAFII 17 PROTEIN, HUMAN; TAFII-17 PROTEIN, HUMAN; TRANSCRIPTION FACTOR IID; VITAMIN D;

ANIMAL CELL; ARTICLE; BONE MARROW CULTURE; MEASLES VIRUS; MOUSE; NONHUMAN; OSTEOCLAST; PAGET BONE DISEASE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; STEM CELL; TRANSCRIPTION INITIATION; BONE MARROW CELL; CELL LINE; CYTOLOGY; DRUG EFFECT; GENE SILENCING; GENETIC TRANSDUCTION; GENETICS; HUMAN; METABOLISM; OSTEOLYSIS; PHYSIOLOGY; SEQUENCE ANALYSIS;

BONE MARROW CELLS; BONE RESORPTION; CELL LINE; DNA, ANTISENSE; GENE SILENCING; HUMANS; NUCLEOCAPSID PROTEINS; NUCLEOPROTEINS; OSTEITIS DEFORMANS; OSTEOCLASTS; PROTEIN INTERACTION MAPPING; RECEPTORS, CALCITRIOL; SEQUENCE ANALYSIS, PROTEIN; TRANSCRIPTION FACTOR TFIID; TRANSDUCTION, GENETIC; VIRAL CORE PROTEINS; VITAMIN D;

EID: 15244347056     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.040312     Document Type: Article

References (23)

1. Hosking DJ 1981 Paget's disease of bone. BMJ 283:686-688.
2. Mills BG, Singer FR, Weiner LP, Suffin SC, Stabile E, Holst P 1984 Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget's disease of bone. Clin Orthop 183:303-311.
3. Basle MF, Russell WC, Goswami KA, Rebel A, Giraudon P, Wild R, Filmon R 1985 Paramyxovirus antigens in osteoclasts from Paget's bone tissue detected by monoclonal antibodies. J Gen Virol 66:2103-2110.
4. Gordon MT, Mee AP, Anderson DC, Sharpe PT 1995 Canine bone marrow cultures infected with canine distemper virus: An in vitro model of Paget's disease. Bone 19:461S-466S.
5. Basle MF, Fournier JG, Rozenblatt S, Rebel A, Bouteille M 1986 Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization. J Gen Virol 67:907-913.
6. Reddy SV, Singer FR, Mallette L, Roodman GD 1996 Detection of measles virus nucleocapsid transcripts in circulating blood cells and hematopoietic progenitors from patients with Paget's disease. J Bone Miner Res 11:1602-1607.
7. Yates AJ 1988 Paget's disease of bone. Baillieres Clin Endocrinol Metab 2:267-295.
8. Kukita A, Chenu C, McManus LM, Mundy GR, Roodman GD 1990 Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease. J Clin Invest 85:1280-1286.
9. Kurihara N, Reddy SV, Menaa C, Anderson D, Roodman GD 2000 Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype. J Clin Invest 105:607-614.
10. 3 hypersensitivity of osteoclast precursors from patient with Paget's disease. J Bone Miner Res 15:228-236.
11. Trost BM, Dumas J 1992 New strategy for the total synthesis of 1α-hydroxyvitamin D derivatives. J Am Chem Soc 114:1924-1925.
12. 3 receptors. Cell 65:1255-1266.
13. Yamagisawa J, Yanagi Y, Mashihiro Y, Suzawa M, Watanabe M, Kashiwagi K, Toriyabe T, Kawabata M, Miyazono K, Kato S 2000 Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283:1317-1321.
14. Kuwahara H, Araki N, Makino K, Honda S, Kaibuchi K, Fukunaga K, Miyamoto E, Ogawa M, Saya H 1999 A novel NE-dlg/SAP102-associated protein, p51-nedasin, related to the amidohydrolase superfamily, interferes with the association between NE-dlg/SAP102 and N-methyl-D-aspartate receptor. J Biol Chem 274:32204-32214.
15. Hoffmann A, Roeder RG 1996 Cloning and characterization of human TAF20/15. J Biol Chem 271:18194-18202.
16. 3 analogue toward vitamin D receptor function. J Biol Chem 274:32376-32381.
17. Manolagas SC, Yu XP, Girasole C, Bellido T 1994 Vitamin D and the hematolymphopoietic tissue: A 1994 update. Semin Nephrol 14:129-143.
18. II28: Three subunits of the human transcription factor TFIID. EMBO J 14:1520-1531.
19. 3 and thyroid hormone receptor. J Biol Chem 275:10054-10071.
20. Hoffmann A, Oelgeschlager T, Roeder RG 1997 Consideration of transcriptional control mechanisms: Do TFIID-core promoter complexes recapitulate nucleosome-like functions. Proc Natl Acad Sci USA 94:8928-8893.
21. II-40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. Cell 75:519-530.
22. Verrizer CP, Yokomori K, Chen JL, Tjian R 1994 Dorsophia TAFII-105: Similarity to yeast geneTSM-1 and specific binding to core promoter DNA. Science 264:933-942.
23. Frieman RN, Albright SR, Zheng S, Sha WC, Hammer RE, Tjian R 2001 Requirement of tissue selective TBP-associated factor TAFII-105 in ovarian development. Science 293:2084-2087.